{"SPADE_UN_08060": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 6884776 B1", "Patent Link": "http://www.lens.org/lens/patent/US_6884776_B1", "Patent Type": "Granted Patent", "Publication Date": "2005-4-26", "Family Info": "CA2291894A1,DE69840024D1,EP1003854A1,EP1003854B1,WO1998054314A1", "Patent Title": "Antimicrobial peptides derived from ubiquicidine.", "Abstract": "The invention relates to the use of ubiquicidine or optionally modified peptide fragments derived therefrom for the preparation of a drug for the treatment, diagnostics or prophylaxis of infections in humans and animals. A peptide fragment derived from ubiquicidine comprises for instance a preferably continuous series of at least 3, preferably at least 7-13 amino acids from the amino acid sequence of ubiquicidine."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08060", "Sequence": "AGKVRGQTPKVAKQEKKKKKT", "Sequence Length": 21, "Peptide Name": "Sequence 11 from Patent US 6884776", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "KAG", "Absent Amino Acids": "CDFHILMNOSUWY", "Basic Residues": 9, "Acidic Residues": 1, "Hydrophobic Residues": 5, "Polar Residues": 17, "Positive Residues": 9, "Negative Residues": 1, "Mass": 2338.8, "PI": 10.82, "Net Charge": 8, "Hydrophobicity": -1.81, "Similar Sequences": [{"SPADE_ID": "SPADE_N_15595", "Similarity": 1.0, "Sequence": "KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPNANS"}, {"SPADE_ID": "SPADE_UN_08051", "Similarity": 1.0, "Sequence": "KVHGSLARAGKVRGQTPK"}, {"SPADE_ID": "SPADE_UN_08059", "Similarity": 1.0, "Sequence": "KVHGSLARAGKVRGQTPKVAKQ"}]}}}